---
$id: https://graph.org.ai/products/commodity/51151643
$type: Product
source: UNSPSC
code: "51151643"
title: "Hexocyclium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hexocyclium

**UNSPSC Code**: 51151643
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C20H33N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LL3147PI1T. European Medicines Agency schedules hexocyclium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02515MIG. HEXOCYCLIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HEXOCYCLIUM remains the US FDA Preferred Term for this commodity. Hexocyclium bears US NLM identifiers UMLS ID C0062674 and NCI Concept Code C78074. SMILES: OC(C1CCCCC1)(CN1CC[N](CC1)(C)C)C1CCCCC1. .

